BioAtla Inc (BCAB)
2.985
-0.14
(-4.63%)
USD |
NASDAQ |
May 09, 10:57
BioAtla Total Assets (Quarterly): 119.66M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 119.66M |
| September 30, 2023 | 151.36M |
| June 30, 2023 | 179.64M |
| March 31, 2023 | 204.55M |
| December 31, 2022 | 225.74M |
| September 30, 2022 | 189.11M |
| June 30, 2022 | 213.50M |
| March 31, 2022 | 230.65M |
| Date | Value |
|---|---|
| December 31, 2021 | 254.42M |
| September 30, 2021 | 277.58M |
| June 30, 2021 | 216.71M |
| March 31, 2021 | 229.09M |
| December 31, 2020 | 244.94M |
| September 30, 2020 | 62.77M |
| December 31, 2019 | 9.336M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.336M
Minimum
Dec 2019
277.58M
Maximum
Sep 2021
187.27M
Average
213.50M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Marinus Pharmaceuticals Inc | 170.91M |
| Equillium Inc | 50.53M |
| Poseida Therapeutics Inc | 273.88M |
| Biomea Fusion Inc | 168.49M |
| Candel Therapeutics Inc | 41.20M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 48.99M |
| Shareholders Equity (Quarterly) | 70.67M |